Terms: = Ovarian cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Staging
200 results:
1. The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial cancer.
Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
[TBL] [Abstract] [Full Text] [Related]
2. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
[TBL] [Abstract] [Full Text] [Related]
3. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
4. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
[TBL] [Abstract] [Full Text] [Related]
5. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract] [Full Text] [Related]
6. Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation.
Ghanem AI; Bhatnagar A; Elshaikh M; Hijaz M; Elshaikh MA
Am J Clin Oncol; 2023 Dec; 46(12):537-542. PubMed ID: 37679878
[TBL] [Abstract] [Full Text] [Related]
7. Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer.
Van Trappen P
Best Pract Res Clin Obstet Gynaecol; 2023 Aug; 90():102402. PubMed ID: 37619486
[TBL] [Abstract] [Full Text] [Related]
8. Robotic surgery in ovarian cancer.
Gallotta V; Certelli C; Oliva R; Rosati A; Federico A; Loverro M; Lodoli C; Foschi N; Lathouras K; Fagotti A; Scambia G
Best Pract Res Clin Obstet Gynaecol; 2023 Aug; 90():102391. PubMed ID: 37573801
[TBL] [Abstract] [Full Text] [Related]
9. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary.
Mazina V; Devins K; Philp L; Bercow AS; James K; Bregar A; Sisodia RC; Oliva E; Del Carmen M
Int J Gynecol Cancer; 2023 Sep; 33(9):1434-1439. PubMed ID: 37567599
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Hospital Case-Volume on Mortality after ovarian cancer Surgery: A Population-Based Retrospective Cohort Study.
Kim BR; Kim H; Joo SG; Jang EJ; Jo J; Lee H; Ryu HG
Gynecol Obstet Invest; 2022; 87(6):364-372. PubMed ID: 36044873
[TBL] [Abstract] [Full Text] [Related]
11. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
12. Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?
Algera MD; van Driel WJ; van de Vijver KK; Kruitwagen RFPM; Lok CAR
Curr Opin Oncol; 2022 Sep; 34(5):497-503. PubMed ID: 35838205
[TBL] [Abstract] [Full Text] [Related]
13. Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria.
Ladjouze A; Donaldson M; Plotton I; Djenane N; Mohammedi K; Tardy-Guidollet V; Mallet D; Boulesnane K; Bouzerar Z; Morel Y; Roucher-Boulez F
Front Endocrinol (Lausanne); 2022; 13():867073. PubMed ID: 35757411
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer.
Moruzzi MC; Bolomini G; Esposito R; Mascilini F; Ciccarone F; Quagliozzi L; Giudice MT; Beneduce G; Ficarelli S; Moroni R; Scambia G; Fagotti A; Testa AC; Moro F
Am J Obstet Gynecol; 2022 Oct; 227(4):601.e1-601.e20. PubMed ID: 35752305
[TBL] [Abstract] [Full Text] [Related]
15. Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery.
Matsuo K; Klar M; Barakzai SK; Jooya ND; Nusbaum DJ; Shimada M; Roman LD; Wright JD
Arch Gynecol Obstet; 2023 Feb; 307(2):525-532. PubMed ID: 35595998
[TBL] [Abstract] [Full Text] [Related]
16. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract] [Full Text] [Related]
17. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
Int J Gynecol Cancer; 2022 Apr; 32(4):525-531. PubMed ID: 34969829
[TBL] [Abstract] [Full Text] [Related]
18. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
duPont NC; Enserro D; Brady MF; Moxley K; Walker JL; Cosgrove C; Bixel K; Tewari KS; Thaker P; Wahner Hendrickson AE; Rubin S; Fujiwara K; Casey AC; Soper J; Burger RA; Monk BJ
Gynecol Oncol; 2022 Feb; 164(2):398-405. PubMed ID: 34857397
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract] [Full Text] [Related]
[Next]
